Theme · live manifest · live theme JSON
Biotech '25: RNA-Based/Genetic Medicine
7 tickers · $29.22B total market cap
Group: Biotech
Biotech '25: RNA-Based/Genetic Medicine tracks 7 publicly listed stocks in this theme: ARWR, DYN, FDMT, IONS, LRMR, SLN, TWST. See the constituent table for details.
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc.IONS | 04/29/2026 (BMO) | 04/29/2026 (BMO) | -5.68% | 4.15% | -10.94% | -1.23% | $12.20B | 14.2857 |
Arrowhead Pharmaceuticals, Inc.ARWR | 05/07/2026 (AMC) | 05/07/2026 (AMC) | -0.19% | -8.15% | 20.82% | 0.67% | $10.31B | 14.2857 |
Twist Bioscience CorporationTWST | 05/04/2026 (BMO) | 05/04/2026 (BMO) | 12.78% | -6.13% | 30.40% | -12.70% | $3.08B | 14.2857 |
Dyne Therapeutics, Inc.DYN | 05/11/2026 (BMO) | 05/11/2026 (BMO) | -6.53% | 4.32% | 20.62% | -13.34% | $2.63B | 14.2857 |
4D Molecular Therapeutics, Inc.FDMT | 05/07/2026 (AMC) | 05/07/2026 (AMC) | 0.58% | -2.69% | 15.33% | -17.06% | $439.4M | 14.2857 |
Larimar Therapeutics, Inc.LRMR | 05/14/2026 (AMC) | 05/14/2026 (AMC) | 0.45% | -12.68% | -13.36% | -6.98% | $285.0M | 14.2857 |
Silence Therapeutics plcSLN | 05/07/2026 (BMO) | 05/07/2026 (BMO) | 7.79% | -5.30% | 18.14% | -17.22% | $272.5M | 14.2857 |
| Average | 1.32% | -3.78% | 11.57% | -9.69% | $4.17B | 14.2857 | ||
| Median | 0.45% | -5.30% | 18.14% | -12.70% | $2.63B | 14.2857 | ||
| Std Dev | 6.41% | 5.80% | 15.62% | 6.76% | $4.63B | 0.0% | ||
| Min | -6.53% | -12.68% | -13.36% | -17.22% | $272.5M | 14.2857 | ||
| Max | 12.78% | 4.32% | 30.40% | 0.67% | $12.20B | 14.2857 | ||
| % Positive Tickers | 57.14% | 28.57% | 71.43% | 14.29% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.